Dan is an Associate in the Intellectual Property Section in the firm's Boston office. His work involves domestic and foreign patent prosecution primarily in the area of biotechnology, including the fields of cellular and molecular biology, oncology, immunology, microbiology, biochemistry, pharmaceuticals, stem cells, RNAi, medical devices, and probiotics.
Dan has experience drafting patent validity and infringement opinions, freedom-to-operate opinions, and due diligence evaluations of patent portfolios. He has worked with a broad range of clients, from small biotech start-ups and universities to established pharmaceutical companies. Dan has also authored and presented scientific publications in the fields of immunology, microbiology, parasitology, and ophthalmology.
Prior to joining Mintz Levin, Dan received his Ph.D. in Molecular Microbiology from the University of Texas Southwestern Medical Center at Dallas. His doctoral dissertation focused on characterizing the pathogenic cascade of Acanthamoeba keratitis, a sight-threatening infection of the ocular surface. He was also the recipient of a doctoral training fellowship awarded by UT Southwestern and a grant-in-aid of research from the National Academy of Sciences, awarded by Sigma Xi, the Scientific Research Society.
Dan holds a B.A. degree from the University of Texas at Austin and a J.D. degree from Suffolk University Law School, where he earned the award for the Best Legal Brief in the First Year Legal Practice Skills Program. He graduated with Distinction from Suffolk Law School's Intellectual Property Concentration, completed the Patent Law Specialization, and is registered to practice before the U.S. Patent and Trademark Office. Dan is a member of the Boston Patent Law Association and a nominated member of Sigma Xi, the Scientific Research Society.